MYX 5.10% $5.36 mayne pharma group limited

$2 here we come...., page-909

  1. 649 Posts.
    lightbulb Created with Sketch. 23
    @Phillgood , I certainly do hold a great many shares in Mayne more than two years now and no I'm not happy with being down 50% if this goes to .65% . Obviously would crazy to walk away with a likely 50% loss I'm simply living in hope the Chairman and Roger Corbett ( director holding a massive BOUGHT holding ) can find a solution between them perhaps by how they deliver the end of the financial year report to the market , any thing to improve sentiment because right now its on the floor . The Chairman and Roger Corbett have been very successful partners in the past @daicosisgod ( proven track record ) and having two proven extremely successful ex business partners in MYX and the added incentive of the massive ( bought) holding Mathieson has in the stock gives me some confidence things hopefully wont deteriorate much further given the negativity in the market in general . As for CEO I agree with Simply Wall St. " is Mayne Pharma Group Ltd (ASX) pay fair ? dated April 24,2018 In the medium term from now I do and always have mentioned with the up and coming potentially big money generating products announced in the pipeline plus new plant and the massive US population , enough things going to plan MYX could well become a mid cap company and who knows long term . @jamarco has messed with pretty much everything of mine posted , can make up your mind as regards that , he's actually very skilled doing this ,lots of practice I'm guessing its in some peoples nature .
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$5.36
Change
0.260(5.10%)
Mkt cap ! $393.8M
Open High Low Value Volume
$5.11 $5.36 $5.11 $1.162M 220.1K

Buyers (Bids)

No. Vol. Price($)
1 568 $5.33
 

Sellers (Offers)

Price($) Vol. No.
$5.37 525 1
View Market Depth
Last trade - 16.10pm 02/12/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.